Our aim is to investigate the clinicopathological and prognostic value of SOX9 expression in GC patients.<h4>Methods</h4>A systemic literature search and meta-analysis were used to evaluate the clinicopathological significance and overall survival (OS) of SOX9 expression in GC patients. The gene discussed is SOX9; the disease is gastric cancer.